Details about Anupam B. Jena

Access statistics for papers by Anupam B. Jena.

Last updated 2023-03-10. Update your information in the RePEc Author Service.

Short-id: pje47

Working Papers

2024

1. Halloween, ADHD, and Subjectivity in Medical Diagnosis
   NBER Working Papers, National Bureau of Economic Research, Inc

2023

2. Occupational Hazard? An Analysis of Birth Outcomes Among Physician Mothers
   NBER Working Papers, National Bureau of Economic Research, Inc

2021

3. How do Physicians Respond to Malpractice Allegations? Evidence from Florida Emergency Departments
   NBER Working Papers, National Bureau of Economic Research, Inc

2019

4. Is Great Information Good Enough? Evidence from Physicians as Patients
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)

2016

5. Self-insuring against Liability Risk: Evidence from Physician Home Values in States with Unlimited Homestead Exemptions
   NBER Working Papers, National Bureau of Economic Research, Inc

2014

6. Does Medical Malpractice Law Improve Health Care Quality?
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)

2011

7. The Pragmatist's Guide to Comparative Effectiveness Research
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (13)
   See also Journal Article The Pragmatist's Guide to Comparative Effectiveness Research, Journal of Economic Perspectives, American Economic Association (2011) View citations (10) (2011)

2009

8. An Economic Evaluation of the War on Cancer
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
   See also Journal Article An economic evaluation of the war on cancer, Journal of Health Economics, Elsevier (2010) View citations (23) (2010)
9. Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (20)

2008

10. The Value of Life in General Equilibrium
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)

2006

11. Health Care, Technological Change, and Altruistic Consumption Externalities
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
12. Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (11)

2005

13. Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)
    See also Journal Article Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs, Forum for Health Economics & Policy, De Gruyter (2006) View citations (28) (2006)

Journal Articles

2011

1. The Pragmatist's Guide to Comparative Effectiveness Research
   Journal of Economic Perspectives, 2011, 25, (2), 27-46 View citations (10)
   See also Working Paper The Pragmatist's Guide to Comparative Effectiveness Research, NBER Working Papers (2011) View citations (13) (2011)
2. The impact of comparative effectiveness research on health and health care spending
   Journal of Health Economics, 2011, 30, (4), 695-706 View citations (13)

2010

3. Altruism and Innovation in Health Care
   Journal of Law and Economics, 2010, 53, (3), 497 - 518 View citations (3)
4. An economic evaluation of the war on cancer
   Journal of Health Economics, 2010, 29, (3), 333-346 View citations (23)
   See also Working Paper An Economic Evaluation of the War on Cancer, NBER Working Papers (2009) View citations (5) (2009)
5. The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000
   Forum for Health Economics & Policy, 2010, 13, (2), 22 View citations (5)
6. The economics of intense exercise
   Journal of Health Economics, 2010, 29, (3), 347-352 View citations (33)

2009

7. `Me-Too' Innovation in Pharmaceutical Markets
   Forum for Health Economics & Policy, 2009, 12, (1), 21 View citations (7)
   See also Chapter "Me-Too" Innovation in Pharmaceutical Markets, NBER Chapters, 2009 (2009) View citations (4) (2009)

2008

8. Cost-effectiveness analysis and innovation
   Journal of Health Economics, 2008, 27, (5), 1224-1236 View citations (26)

2007

9. The institute of medicine report on the FDA: where is the science?
   Health Economics, 2007, 16, (3), 219-221

2006

10. Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
    Forum for Health Economics & Policy, 2006, 9, (2), 33 View citations (28)
    See also Working Paper Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs, NBER Working Papers (2005) View citations (7) (2005)

Chapters

2009

1. "Me-Too" Innovation in Pharmaceutical Markets
   A chapter in Frontiers in Health Policy Research, volume 12, 2009 View citations (4)
   See also Journal Article `Me-Too' Innovation in Pharmaceutical Markets, De Gruyter (2009) View citations (7) (2009)